Tags : Chronic Kidney Diseases


ViewPoints Interview: AstraZeneca’s Global Medicine Leader John Houghton Shares Insights

AstraZeneca presented P-III data of Roxadustat along with unprecedented 41 abstracts from its renal portfolio at American Society of Nephrology Kidney Week 2019, demonstrating its commitment to advancing the care of Chronic Kidney Diseases (CKD) and its complications, affecting millions of people across the globe. On Nov 12, 2019 in an interview with PharmaShots, John […]Read More